Fingerprint
Dive into the research topics of 'Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically